Annexon, Inc.
Anti-complement factor C1q Fab fragments and uses thereof

Last updated:

Abstract:

The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.

Status:
Grant
Type:

Utility

Filling date:

23 Nov 2016

Issue date:

28 Jul 2020